ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0351

Needs Assessment Survey of Critical Data Element Completion in Telemedicine Visits for Juvenile Idiopathic Arthritis in the Post-Pandemic Period

Kristen Hayward1, Y. Ingrid Goh2, Mary Toth3, Jenny Leal4, Alice Liu5, Nidji Naik5, Jade Singleton5, Jackson Youn5 and Esi Morgan5, 1Seattle Children's Hospital/University of Washington School of Medicine, Seattle, WA, 2The Hospital for Sick Children, Toronto, ON, Canada, 3Nemours Foundation, Orlando, FL, 4Nationwide Children's, Columbus, OH, 5Seattle Children's Hospital, Seattle, WA

Meeting: ACR Convergence 2023

Keywords: Access to care, Juvenile idiopathic arthritis, quality of care

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 12, 2023

Title: (0345–0379) Pediatric Rheumatology – Clinical Poster I: JIA

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Juvenile Idiopathic Arthritis (JIA) affects 1 in 1,000 children in the United States (US). There is a shortage of pediatric rheumatologists across North America and many patients travel lengthy distances to access subspecialty care. Telemedicine is a potential solution to this distance barrier. Although use of telemedicine has substantially increased since the COVID-19 pandemic, questions remain about the role of virtual visits for monitoring of patients with JIA where hands-on assessments have been the cornerstone for care. Surveys from early in the pandemic indicated that critical data elements (CDE) for Treat-to-Target decision making such as active joint count, physician global assessment (PGA) and patient reported outcomes (PROs) were under-reported in telemedicine relative to in-person visits.1,2 The global aim of this quality improvement effort is to optimize completion of CDE for JIA patients seen via telemedicine, targeting the same rate as in-person visits. To determine primary drivers of CDE in telemedicine visits as well as to inform ideas for change, we performed a needs assessment of post-pandemic telemedicine practices of the Pediatric Rheumatology Care and Outcomes Improvement Network (PR-COIN) network.

Methods: PR-COIN is a multi-center learning collaborative spanning 24 pediatric centers across the US and Canada. A REDCap survey regarding current telemedicine practices was emailed to the faculty representative for each PR-COIN site in January 2023. Quantitative responses were analyzed with descriptive statistics. Qualitative comments were thematically grouped.

Results: Responses were received from 21/24 sites (88%). Figure 1 demarcates CDE collected by visit modality. Figure 2 notes the methods of PRO collection by visit type. Only 2 sites reported that providers use a standard method to assess active joint counts in telemedicine visits. However, most respondents (15/21) indicated that providers used modifications of the ‘video’ pediatric Gait Arms Legs and Spine (vpGALS) tool for virtual joint exams.

Reported barriers to CDE collection during telemedicine visits were grouped into three categories of primary drivers: patient engagement, provider engagement and electronic medical record(EMR)/support staff (Figure 3). Opportunities to improve standard collection of CDE included development of educational materials, easy/automated collection methods, enhanced use of support staff, streamlined questionnaires and standardized templates for virtual physical exams.

Conclusion: Despite three years of telemedicine experience, CDE completion for JIA patients in virtual visits lags behind rates for in-person visits. We are currently developing resources including instructional videos, templates and best practices for providers, patients and EMR/support staff to address these gaps. We plan to implement these interventions at network sites using an iterative quality improvement approach and prospectively track rates of CDE completion.

References
1. Goh YI, et al. Frontiers in Pediatrics. 2021 Mar 4;9:642460.
2. Ryan ME, et al. Pediatr Rheumatol Online J. 2022 Sep 29;20(1):83.

Supporting image 1

Figure 1: Specific CDE collected during JIA visits by visit modality

Supporting image 2

Figure 2: Methods of PRO collection during JIA visits by visit modality

Supporting image 3

Figure 3: Key Driver Diagram based on PR-COIN network needs assessment survey


Disclosures: K. Hayward: AbbVie/Abbott, 11, CIGNA/Express Scripts, 11, Merck/MSD, 11, Teva, 11; Y. Goh: None; M. Toth: None; J. Leal: None; A. Liu: None; N. Naik: None; J. Singleton: None; J. Youn: None; E. Morgan: None.

To cite this abstract in AMA style:

Hayward K, Goh Y, Toth M, Leal J, Liu A, Naik N, Singleton J, Youn J, Morgan E. Needs Assessment Survey of Critical Data Element Completion in Telemedicine Visits for Juvenile Idiopathic Arthritis in the Post-Pandemic Period [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/needs-assessment-survey-of-critical-data-element-completion-in-telemedicine-visits-for-juvenile-idiopathic-arthritis-in-the-post-pandemic-period/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/needs-assessment-survey-of-critical-data-element-completion-in-telemedicine-visits-for-juvenile-idiopathic-arthritis-in-the-post-pandemic-period/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology